Contact Us

Sylvie Abbadie Honored for Success in Pharmaceuticals

At Pierre Fabre, Dr. Abbadie has both regulatory, reimbursement and economic affairs knowledge.
  • <strong>Sylvie Abbadie</strong>

Dr. Abbadie's duties in her current role of a year are overseeing pricing and reimbursement, developing and leading the execution of market access strategies for drugs and medical devices in France

    BOULOGNE-BILLANCOURT, FRANCE, May 12, 2014 /24-7PressRelease/ -- Sylvie Abbadie, Ph.D., and the Market Access Director of France of Pierre Fabre, has been recognized by Worldwide Branding for showing dedication, leadership and excellence in reimbursement and economic affairs.

With more than two decades of industry experience, Dr. Abbadie's expertise is in oncology, dermatology, cardiology, diabetes, CNS drugs and medical devices. She is also well versed in marketing and regulatory affairs.

Dr. Abbadie's duties in her current role of a year are overseeing pricing and reimbursement, developing and leading the execution of market access strategies for drugs and medical devices in France, demonstrating the value of drugs and medical devices of PFM and PFD to payers, and obtaining access to new markets. In the future, she aims to experience continued career success, which she attributes to her tenacity and perfectionism.

After earning a Ph.D. in pharmacy from the University of Toulouse in 1993, Dr. Abbadie started working as a pharmacist before progressing to her current position. She also maintains affiliations with numerous trade groups, including AFAR; the Health Economics ; Market Access; Government Affairs & Pricing Reimbursement Opportunities; the Global Health Economics Network; Health Economics & Market Access; the Life Sciences Reimbursement Group; Pharma France; Pharmaceutical Reimbursement & Market Access for Europe; Oncology Pricing & Reimbursement; the Pricing Strategies Group and the Pricing Solutions Club.

In recognition of all her achievements, she was recently inducted into Worldwide Branding. For more information about Dr. Abbadie, visit http://www.linkedin.com/pub/sylvie-abbadie/13/976/b1b.

Pierre Fabre is a pharmaceutical company that provides related research and product development.

About Worldwide Branding
For over 15 years, Worldwide Branding has been the leading, one-stop-shop, personal branding company, both in the United States and abroad. From writing professional biographies and press releases, to creating and driving traffic to personal websites, our team of branding experts tailor each product specifically for our clients needs. We are dedicated to empowering our 600,000 clients with effective branding tools to help them achieve success. From healthcare to finance to education and law, our constituents represent every major industry and occupation, at all career levels.

An international company, we provide our members with access to members in over 52 countries including, the United States, Canada, Australia, the United Kingdom, France, The Netherlands, Germany, Ireland, Spain, Switzerland, South Africa, Belgium, Mexico, Italy, Brazil, Sweden and The United Arab Emirates, just to name a few.

We presently have two offices, but we are headquartered on Long Island. Our team comprises more than 100 staff members and spans 10 key departments.

For more information, please visit http://www.worldwidebranding.com.

Contact:
Ellen Campbell
Director, Media Relations
mediarelations@worldwidebranding.com


# # #

Read more Press Releases from Ellen Campbell:


Comment on this story...

Share This Story


Email this Story

Contact Information


Ellen Campbell
Worldwide Branding

Uniondale, NY
USA
Voice: (516) 833-8440
E-Mail: Email Us Here
Website: Visit Our Website

Like This Story?


I like it! 0

Disclaimer


If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release Newswire. We are unable to assist you with any information regarding this release. 24-7 Press Release Newswire disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.